Select the drug indication to add to your list


Miscellaneous ocular agents
Only 4 drugs may be compared at once

Generic Name and Formulations:

Ocriplasmin 2.5mg/mL; per vial; soln for intravitreal inj after dilution; contains mannitol; preservative- and latex-free.

Select therapeutic use:

Indications for JETREA:

Treatment of symptomatic vitreomacular adhesion.


Give by intravitreal inj. 0.125mg (0.1mL of the diluted soln) once as a single dose to the affected eye.


Not recommended.


For ophthalmic intravitreal inj only. Monitor for elevation in intraocular pressure immediately after inj. Monitor for decreased vision. Repeated administration in the same eye: not recommended. Treatment in the other eye is not recommended within 7 days of the initial inj. Pregnancy (Cat.C). Nursing mothers.

Pharmacological Class:

Proteolytic enzyme.

Adverse Reactions:

Vitreous floaters, conjunctival hemorrhage, eye pain, photopsia, blurred vision, macular hole, reduced visual acuity, visual impairment, retinal edema; intraocular inflammation/infection/hemorrhage, increased intraocular pressure, yellowish vision.

Generic Availability:


How Supplied:

Single-use vial (0.2mL)—1

JETREA 0.2ml of 2.5mg/ml vials (Qty:1)

appx. price $4135.00